Induction of protective antibodies in Saimiri monkeys by immunization with a multiple antigen construct (MAC) containing the Plasmodium vivax circumsporozoite protein repeat region and a universal T helper epitope of tetanus toxin

Vaccine

Volumn 15, Issue 4, 1997, Pages 377-386

  Yang, Chunfu ^a   Collins, William E ^a   Xiao, Lihua ^a   Saekhou, Ae M ^a   Reed, Robb C ^a   Nelson, Cecilia O ^a   Hunter, Robert L ^a   Jue, Danny L ^b   Fang, Sunan ^b   Wohlhueter, Robert M ^b   Udhayakumar, Venkatachalam ^a   Lal, Altaf A ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

malaria; multiple antigen construct (MAC); protection

Indexed keywords

EPITOPE; MALARIA VACCINE; TETANUS TOXIN;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNIZATION; INTRAMUSCULAR DRUG ADMINISTRATION; MALARIA; MALE; MONKEY; NONHUMAN; PLASMODIUM VIVAX; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 20244388248     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00200-4     Document Type: Article

References (33)

1. Institute of Medicine. In: Malaria, Obstacles and Opportunities (Eds Oaks, Jr. S.C., Mitchell, V.S., Perason, G.W. and Carpenter, C.C). National Academy Press, Washington, D.C., 1991, pp. 1-21
2. Arnot, D.E., Barnwell, J.W., Tarn, J.P., Nussenzweig, V., Nussenzweig, R.S. and Enea, V. Circumsporozoite protein of Plasmodium vivax, gene cloning and characterization of the immunodominant epitope. Science 1985, 230, 815-818
3. McCutchan, T.F., Lal, A.A., de la Cruz, V.F. el al. Sequence of the immunodominant epitope for the surface protein on sporozoites of Plasmodium vivax. Science 1985, 230, 1381-1383
4. del Portillo, H.A., Longacre, S., Khouri, E. and David, P.M. Primary structure of the merozoite surface antigen 1 of Plasmodium vivax reveals sequences conserved between different Plasmodium species. Proc. Natl Acad. Sci. USA 1991, 88, 4030-4034
5. Fang, X.D., Kaslow, D.C., Adams, J.H. and Miller, L.H. Cloning of the Plasmodium vivax duffy receptor. Mol. Biochem. Parasitol. 1991, 44, 125-132
6. Galinski, M.R., Medina, C.C., Ingravallo, P. and Barnwell, J.W. A reticulocyte-binding protein complex of Plasmodium vivax merozoites. Cell 1992, 69, 1213-1226
7. Snewin, V.A., Khouri, E., Wattavidanage, J. et al. A new polymorphic marker for PCR typing of Plasmodium vivax parasites. Mol. Biochem. Parasitol. 1995, 71, 135-138
8. Nardin, E.H., Nussenzweig, V., Nussenzweig, R.S. et al. Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax. J. Exp. Med. 1982, 156, 20-30
9. Potocnjak, P., Yoshida, N., Nussenzweig, R.S. and Nussenzweig, V. Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection. J. Exp. Med. 1980, 151, 1504-1513
10. Egan, J.E., Weber, J.L., Ballou, W.R. et al. Efficacy of murine malaria sporozoite vaccines: implications for human vaccine development. Science 1987, 236, 453-456
11. Charoenvit, Y., Mellouk, S., Cole, C. et al. Monoclonal, but not polyclonal, antibodies protect against Plasmodium yoelii sporozoites. J. Immunol. 1991, 146, 1020-1025
12. Charoenvit, Y., Collins, W.E., Jones, T.R. et al. Inability of malaria vaccine to induce antibodies to a protective epitope within its sequence. Science 1991, 251, 668-671
13. Collins, W.E., Nussenzweig, R.S., Ballou, W.R. et al. Immunization of Saimiri sciureus boliviensis with recombinant vaccines based on the Circumsporozoite protein of Plasmodium vivax. Am. J. Trop. Med. Hyg. 1989, 40, 455-464
14. Collins, W.E., Nussenzweig, R.S., Ruebush, T.K.II et al. Further studies on the immunization of Saimiri sciureus boliviensis with recombinant vaccines based on the Circumsporozoite protein of Plasmodium vivax. Am. J. Trop. Med. Hyg. 1990, 43, 576-583
15. Gordon, D.M., Cosgriff, T.M., Schneider, I. et al. Safety and immunogenicity of a Plasmodium vivax sporozoite vaccine. Am. J. Trop. Med. Hyg. 1990, 42, 527-531
16. Herrington, D.A., Nardin, E.H., Losonsky, G. et al. Safety and immunogenicity of a recombinant sporozoite malaria vaccine against Plasmodium vivax. Am. J. Trop. Med. Hyg. 1991, 45, 695-701
17. Jones, T.R., Yuan, L.F., Marwoto, H.A., Gordon, D.M., Wirtz, R.A. and Hoffman, S.L. Low immunogenicity of a Plasmodium vivax circumsporozoite protein epitope bound by a protective monoclonal antibody. Am. J. Trop. Med. Hyg. 1992, 47, 837-843
18. Tarn, J.P. Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system. Proc. Natl Acad. Sci. USA 1988, 85, 5409-5413
19. Tam, J.P., Clavijo, P., Lu, Y., Nussenzweig, V., Nussenzweig, R.S., Zavala, F. Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria. J. Exp. Med. 1990, 171, 299-306
20. Zavala, F. and Chai, S. Protective anti-sporozoite antibodies induced by a chemically defined synthetic vaccine. Immunol. Lett. 1990, 25, 271-274
21. Wang, R., Charoenvit, Y, Corradin, G. et al. Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine. J. Immunol. 1995, 154, 2784-2793
22. Reed, R.C., Louis-Wileman, V., Cosmai, E.M. et al. Multiple antigen constructs (MACs): induction of sterile immunity against sporozoite stage of rodent malaria parasites, Plasmodium berghei and Plasmodium yoelii. Vaccine, in press
23. Herrera, M.A., de Plata, C., Gonzalez, J.M., Corradin, G. and Herrera, S. Immunogenicity of multiple antigen peptides containing Plasmodium vivax CS epitopes in Balb/c mice. Mem. Inst. Oswaldo Cruz. 1994, 89, 71-76
24. ten Hagen, T.L.M., Sulzer, A.J., Kidd, M.R., Lal, A.A. and Hunter, R.L. Role of adjuvants in the modulation of antibody isotype, specificity, and induction of protection by whole blood-stage Plasmodium yoelii vaccines. J. Immunol. 1993, 151, 7077-7085
25. Hunter, R.L. and Lal, A.A. Copolymer adjuvants in malaria vaccine development. Am. J. Trop. Med. Hyg. 1994, 50 Suppl., 52-58
26. Hunter, R.L., Kidd, M.R., Olsen, M.R., Patterson, P.S. and Lal, A.A. Induction of long-lasting immunity to Plasmodium yoelii malaria with whole blood-stage antigens and copolymer adjuvants. J. Immunol. 1995, 154, 1762-1769
27. Panina-Bordignon, P., Tan, A., Termijtelen, A., Demotz, S., Corradin, G. and Lanzavecchia, A. Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur. J. Immunol. 1989, 19, 2237-2242
28. Valmori, D., Pessi, A., Bianchi, E. and Corradin, G. Use of human universally antigenic tetanus toxin T cell epitopes as carriers for human vaccination. J. Immunol. 1992, 149, 717-721
29. Takayama, K., Olsen, M., Datta, P. and Hunter, R.L. Adjuvant activity of nonionic block copolymers. V. Modulation of antibody isotype by lipopolysaccharides, lipid A and precursors. Vaccine 1991, 9, 257-265
30. Sulzer, A.J., Wilson, M. and Hall, E.G. Indirect fluorescent antibody tests for parasitic diseases. V. An evaluation of a thick-smear antigen in the IFA test for malarial antibodies. Am. J. Trop. Med. Hyg. 1969, 18, 199-205
31. Clyde, D.F., McCarthy, V.C., Miller, R.M. and Woodward, W.E. Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites. Am. J. Trop. Med. Hyg. 1975, 24, 397-401
32. Huffman, S.L., Franke, E.D., Rogers, W.O. and Mellouk S. Preerythrocytic malaria vaccine development. In: Molecular Immunological Considerations in Malaria Vaccine Development (Eds Good, M.F. and Saul, A.J.). CRC Press, London, pp. 149-167
33. Yang, C., Collins, W.E., Patterson, P.S. et al. Influence of adjuvants on murine immune responses against the C-terminal 19 kDa fragment of Plasmodium vivax merozoite surface protein-1 (MSP-1). Parasite Immunol. 1996, 18, 547-558